[Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
D000328:Adult; D000368:Aged; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D004338:Drug Combinations; D006834:Hydrazines; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Die Behandlung des Parkinsonsyndroms mit L-Dopa in Kombination mit einem Decarboxylasehemmer.